Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related VECO
Stifel Slashes Price Targets For These 4 Stocks
Noble Financial Upgrades Veeco Instruments, Cites 'Swelling' Backlog
Related UTHR
5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years
Earnings Scheduled For February 24, 2015

Analysts at B. Riley downgraded Veeco Instruments (NASDAQ: VECO) from “buy” to “neutral.” Veeco's shares closed at $30.55 yesterday. Veeco's trailing-twelve-month ROA is 5.44%.

Analysts at Goldman Sachs downgraded United Therapeutics (NASDAQ: UTHR) from “neutral” to “sell.” United Therapeutics' shares closed at $52.16 yesterday. United Therapeutics' trailing-twelve-month ROE is 24.64%.

Analysts at Jefferies downgraded Nabors Industries (NYSE: NBR) from “hold” to “underperform.” Nabors Industries' shares closed at $14.53 yesterday. Nabors Industries' trailing-twelve-month profit margin is 0.44%.

Keefe Bruyette downgraded Comerica (NYSE: CMA) from “market perform” to “underperform.” Comerica's shares closed at $29.27 yesterday. Comerica's PEG ratio is 0.95.

Latest Ratings for VECO

DateFirmActionFromTo
Feb 2015Stifel NicolausMaintainsBuy
Feb 2015Noble Financial UpgradesHoldBuy
Dec 2014JP MorganMaintainsOverweight

View More Analyst Ratings for VECO
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CMA + NBR)

Around the Web, We're Loving...